Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1314.40 12.05 (0.93%) | NSE 1318.30 13.50 (1.03%) | Trade | Add

BSE Live

Nov 07, 16:01

1314.40 12.05 (0.93%)

Volume

AVERAGE VOLUME

5-Day

5,350

10-Day

16,400

30-Day

9,412

13,477

Prev. Close

1302.35
Open Price

1282.75

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Nov 07, 15:55

1318.30 13.50 (1.03%)

Volume

AVERAGE VOLUME

5-Day

127,604

10-Day

111,595

30-Day

140,740

281,388

Prev. Close

1304.80
Open Price

1304.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1318.30 (75)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Ipca Laboratories (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
Per Share Ratios
Basic EPS (Rs.)	20.15	37.92	25.65	21.98	20.96
Diluted EPS (Rs.)	20.15	37.92	25.65	21.97	20.95
Cash EPS (Rs.)	34.76	46.06	32.59	27.28	25.31
Book Value [ExclRevalReserve]/Share (Rs.)	174.99	155.28	123.12	99.64	83.61
Book Value [InclRevalReserve]/Share (Rs.)	174.99	155.28	123.12	99.64	83.61
Revenue from Operations/Share (Rs.)	248.96	260.05	222.91	187.42	151.14
PBDIT/Share (Rs.)	45.09	60.27	45.53	37.56	33.88
PBIT/Share (Rs.)	30.86	52.10	38.66	32.23	29.44
PBT/Share (Rs.)	28.61	49.97	36.02	28.95	27.10
Net Profit/Share (Rs.)	20.53	37.89	25.72	21.95	20.87
NP After MI And SOA / Share (Rs.)	20.15	37.92	25.64	22.02	20.91
Profitability Ratios
PBDIT Margin (%)	18.11	23.17	20.42	20.04	22.41
PBIT Margin (%)	12.39	20.03	17.34	17.19	19.48
PBT Margin (%)	11.49	19.21	16.15	15.44	17.93
Net Profit Margin (%)	8.24	14.57	11.53	11.70	13.80
NP After MI And SOA Margin (%)	8.09	14.58	11.50	11.74	13.83
Return on Networth/Equity (%)	11.51	24.41	20.82	22.09	24.99
Return on Capital Employed (%)	8.74	19.79	15.68	16.42	19.71
Return on Assets (%)	6.66	14.90	11.99	11.90	13.74
Total Debt/Equity (X)	0.38	0.22	0.34	0.42	0.44
Asset Turnover Ratio (%)	82.41	102.22	104.30	101.34	99.37
Liquidity Ratios
Current Ratio (X)	1.78	2.02	2.21	1.89	1.79
Quick Ratio (X)	0.76	0.95	1.04	0.84	0.99
Inventory Turnover Ratio (X)	3.39	3.87	3.80	3.52	4.07
Dividend Payout Ratio (NP) (%)	4.96	13.18	15.59	14.54	15.29
Dividend Payout Ratio (CP) (%)	2.90	10.84	12.30	11.70	12.62
Earnings Retention Ratio (%)	95.04	86.82	84.41	85.46	84.71
Cash Earnings Retention Ratio (%)	97.10	89.16	87.70	88.30	87.38
Coverage Ratios
Interest Coverage Ratios (%)	13.72	24.46	14.63	9.83	12.59
Interest Coverage Ratios (Post Tax) (%)	13.72	24.46	14.63	9.83	12.59
Valuation Ratios
Enterprise Value (Cr.)	8,762.27	11,023.04	7,110.80	4,735.36	4,238.06
EV/Net Operating Revenue (X)	2.79	3.36	2.53	2.01	2.23
EV/EBITDA (X)	15.40	14.49	12.37	10.02	9.95
MarketCap/Net Operating Revenue (X)	2.56	3.25	2.36	1.79	2.00
Retention Ratios (%)	95.03	86.81	84.40	85.45	84.70
Price/BV (X)	3.65	5.44	4.28	3.36	3.61
Price/Net Operating Revenue	2.56	3.25	2.36	1.79	2.00
Earnings Yield	0.03	0.04	0.05	0.07	0.07